State markers of depression in sleep EEG: dependency on drug and gender in patients treated with tianeptine or paroxetine.
about
A comparison of doubly hierarchical discriminant analyses for multiple class longitudinal data from EEG experiments.Biomarkers in development of psychotropic drugs.Sleep phenotyping in a mouse model of extreme trait anxiety.Clinical relevance of disturbances of sleep and vigilance in major depressive disorder: a reviewComparison of different methods for the evaluation of treatment effects from the sleep EEG of patients with major depression.Taking Personalized Medicine Seriously: Biomarker Approaches in Phase IIb/III Studies in Major Depression and SchizophreniaDorsolateral prefrontal transcranial magnetic stimulation in patients with major depression locally affects alpha power of REM sleep.Guidelines for the recording and evaluation of pharmaco-sleep studies in man: the International Pharmaco-EEG Society (IPEG).Sleep as a biomarker for depression.Changes of sleep architecture, spectral composition of sleep EEG, the nocturnal secretion of cortisol, ACTH, GH, prolactin, melatonin, ghrelin, and leptin, and the DEX-CRH test in depressed patients during treatment with mirtazapine.Progress in Elucidating Biomarkers of Antidepressant Pharmacological Treatment Response: A Systematic Review and Meta-analysis of the Last 15 Years.Acute escitalopram treatment inhibits REM sleep rebound and activation of MCH-expressing neurons in the lateral hypothalamus after long term selective REM sleep deprivation.Sex differences in sleep after a single oral morning dose of olanzapine in healthy volunteers.Atypical depression spectrum disorder - neurobiology and treatment.
P2860
Q33383328-B1959CA0-0C8C-4547-9574-B388B3BA56D0Q33993209-07578ED1-D4F5-4B65-B5D1-0D258DE65AB1Q34342192-599B5760-5AF4-4EB9-BBC8-4BA26EEA1901Q34743018-A5EFFF7E-8A0C-4006-919B-2B8D0801EED2Q34996650-70FAF694-8848-4EA2-A212-D4309027D8D4Q36063627-74FEBFA7-DE44-4789-A86E-06EACF7BF6EFQ37064789-142545CA-B793-408F-913B-ECAB1324B715Q38095247-896B62C8-89DE-472B-82DF-856CB254F0E1Q38154921-1B5FCA7E-60CA-49BC-888D-EC866CBDCFD0Q46764282-3FDBE169-FF85-4C4A-9153-B2B54058EBCCQ47666907-8C7368E7-4D29-48A3-9866-27F9B4F8CE91Q48117353-A1D83B66-A60D-4946-A35F-529FEB7A518DQ48281306-E1484B7A-A1FF-4A61-8CA8-A85738CFD4D5Q52950284-3811E37B-6821-4A2B-B816-0EA529EA5883
P2860
State markers of depression in sleep EEG: dependency on drug and gender in patients treated with tianeptine or paroxetine.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
State markers of depression in ...... with tianeptine or paroxetine.
@en
State markers of depression in ...... with tianeptine or paroxetine.
@nl
type
label
State markers of depression in ...... with tianeptine or paroxetine.
@en
State markers of depression in ...... with tianeptine or paroxetine.
@nl
prefLabel
State markers of depression in ...... with tianeptine or paroxetine.
@en
State markers of depression in ...... with tianeptine or paroxetine.
@nl
P2093
P2860
P356
P1476
State markers of depression in ...... with tianeptine or paroxetine.
@en
P2093
I A Antonijevic
P2860
P2888
P304
P356
10.1038/SJ.NPP.1300029
P407
P577
2003-02-01T00:00:00Z